Compare Stocks → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison TSE:COSNASDAQ:GSDCVE:KNE Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOSCanadian Oil SandsC$0.00C$5.61▼C$13.87N/AN/A2.19 million shsN/AGSDGlobal System Dynamics$11.11$11.16$9.90▼$11.98$36.77MN/A7,280 shs2 shsKNEKane BiotechC$0.13-3.8%C$0.11C$0.05▼C$0.17C$16.48M0.56152,713 shs150,900 shs(Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGSDGlobal System Dynamics0.00%0.00%0.00%-1.24%+5.61%KNEKane Biotech-7.14%-7.14%+30.00%+62.50%+13.04%Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right hereMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCOSCanadian Oil SandsN/AN/AN/AN/AN/AN/AN/AN/AGSDGlobal System DynamicsN/AN/AN/AN/AN/AN/AN/AN/AKNEKane BiotechN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOSCanadian Oil Sands3.00BuyC$0.52∞ UpsideGSDGlobal System DynamicsN/AN/AN/AN/AKNEKane BiotechN/AN/AN/AN/ACurrent Analyst RatingsLatest KNE, COS, GSD, HVO, and RLM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/23/2024COSCanadian Oil SandsFundamental ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuyC$0.52(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOSCanadian Oil SandsN/AN/AN/AN/AN/AN/AGSDGlobal System DynamicsN/AN/AN/AN/A($1.84) per shareN/AKNEKane BiotechC$2.74M6.01C$0.01 per share8.50C($0.07) per share-1.79Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOSCanadian Oil SandsN/AN/A0.00N/AN/AN/AN/AN/AN/AGSDGlobal System Dynamics-$790KN/A0.00∞N/AN/AN/A-2.30%N/AKNEKane Biotech-C$4.32M-C$0.03N/A∞N/A-157.48%N/A-32.70%5/23/2024 (Estimated)Latest KNE, COS, GSD, HVO, and RLM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/26/2024Q4 2023KNEKane BiotechN/A-C$0.01-C$0.01-C$0.01N/AC$0.04 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCOSCanadian Oil SandsN/AN/AN/AN/AN/AGSDGlobal System DynamicsN/AN/AN/AN/AN/AKNEKane BiotechN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOSCanadian Oil SandsN/AN/AN/AGSDGlobal System DynamicsN/A0.010.01KNEKane Biotech1,164.240.370.39OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOSCanadian Oil SandsN/AGSDGlobal System Dynamics24.82%KNEKane BiotechN/AInsider OwnershipCompanyInsider OwnershipCOSCanadian Oil SandsN/AGSDGlobal System Dynamics62.81%KNEKane Biotech36.45%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCOSCanadian Oil Sands147,000N/AN/ANot OptionableGSDGlobal System DynamicsN/A3.31 million1.23 millionNot OptionableKNEKane BiotechN/A131.84 millionN/ANot OptionableKNE, COS, GSD, HVO, and RLM HeadlinesSourceHeadlineKane Biotech Inc. (CVE:KNE) Director Sells C$260,000.00 in Stockinsidertrades.com - April 23 at 4:22 AMKane Biotech (CVE:KNE) Trading Up 8%americanbankingnews.com - April 17 at 5:10 AMKane Biotech Inc.: Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Productsfinanznachrichten.de - April 16 at 2:35 PMKane Biotech to Host Investor Webinartmcnet.com - April 16 at 9:35 AMDual Listed Biotech Firm Achieves Sale of Animal Health Interest, Sending Shares Highermsn.com - April 15 at 1:18 PMKane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Productsstockhouse.com - April 15 at 1:18 PMKane Biotech (CVE:KNE) Shares Down 7.1% americanbankingnews.com - April 14 at 1:42 AM'Light Injuries': Harry Kane's Children In Munich Car Accidentbarrons.com - April 12 at 8:33 PMKane Biotech Inc.: Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Healthfinanznachrichten.de - April 11 at 1:13 PMCanadian Investment Regulatory Organization Trading Halt - KNEca.finance.yahoo.com - April 11 at 1:13 PMCanadian Investment Regulatory Organization Trade Resumption - KNEfinance.yahoo.com - April 11 at 1:13 PMMaddie Kane’s return sparks Bret Harte to its first Mother Lode League victorycalaverasenterprise.com - April 10 at 10:35 AMKane Biotech Inc.: Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 29 at 10:59 AMKane Biotech Announces Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - March 27 at 11:04 AMKane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Healthfinance.yahoo.com - March 20 at 5:09 PMKane Biotech Receives Bioscience Association Manitoba Company of the Year Awardtmcnet.com - March 8 at 1:24 PMChicago Blackhawks brace for Patrick Kane’s return — as a Detroit Red Wing: ‘It’s definitely weird’msn.com - February 24 at 3:42 PMKane Biotech Inc.: Kane Biotech Files New Patent on revyve Antimicrobial Wound Gel Sprayfinanznachrichten.de - January 31 at 12:20 PMKane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Sprayfinancialpost.com - January 31 at 12:20 PMKane Biotech Files New Patent on revyve(TM) Antimicrobial Wound Gel Spraystockhouse.com - January 31 at 12:20 PMKane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposiummarkets.businessinsider.com - January 25 at 6:29 PMKane Biotech Announces Special Meeting of Shareholdersfinance.yahoo.com - January 18 at 7:42 PMKane Biotech Announces Correction to Press Releasefinance.yahoo.com - December 29 at 3:34 PMKane Biotech Inc.: Kane Biotech Announces Improved Third Quarter 2023 Financial Resultsfinanznachrichten.de - November 29 at 10:10 AMMedia Sentiment Over TimeTop HeadlinesPVH Stock Gets 25% Discount: Is Now the Time to Buy?April 2, 2024 11:25 AMView PVH Stock Gets 25% Discount: Is Now the Time to Buy?It’s Time to Buy Into the Super Micro Computer Stock ImplosionApril 22, 2024 12:33 PMView It’s Time to Buy Into the Super Micro Computer Stock Implosion2 Stocks to Buy on The Dip: One a Value, the Other High-YieldingApril 12, 2024 7:32 AMView 2 Stocks to Buy on The Dip: One a Value, the Other High-YieldingThe Bottom is in For Tesla: Read This Before Buying the BounceApril 24, 2024 8:45 AMView The Bottom is in For Tesla: Read This Before Buying the BounceIs Estée Lauder on the Verge Of a Massive Comeback?April 4, 2024 11:10 AMView Is Estée Lauder on the Verge Of a Massive Comeback?All Headlines Company DescriptionsCanadian Oil SandsTSE:COSCanadian Oil Sands Limited is a Canada-based investment company. The Company owns a 36.74% interest in the Syncrude Joint Venture (Syncrude), a producer of low sulphur, light, synthetic crude oil (SCO). Syncrude is involved in the mining and upgrading of bitumen from oil sands near Fort McMurray in northern Alberta. The Syncrude Project is comprised of open-pit oil sands mines, utilities plants, bitumen extraction plants and an upgrading complex that processes bitumen into SCO. Syncrude's leases are located in the Athabasca oil sands deposit. Syncrude produces SCO by mining oil sands, extracting the bitumen from the sands, upgrading the recovered bitumen into lighter oil fractions and combining those fractions into a single SCO product.Global System DynamicsNASDAQ:GSDGlobal System Dynamics, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company focuses its search on the farming and national security sectors, including farming related operations and businesses that support the farming industry. The company was formerly known as Gladstone Acquisition Corporation. Global System Dynamics, Inc. was incorporated in 2021 and is based in Houston, Texas.Kane BiotechCVE:KNEKane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.